Back to Results
First PageMeta Content
Technology / Clinical research / Pharmaceuticals policy / Botulinum toxin / Plastic surgery / Environmental Working Group / Validation / Medical device / Regulatory requirement / Medicine / Neurotoxins / Biology


ZEBET’s Activities to Promote Alternative Methods to the LD50 Potency Test in Botulinum Neurotoxin Product Testing FEDERAL INSTITUTE FOR RISK ASSESSMENT
Add to Reading List

Document Date: 2015-05-26 17:27:56

Open Document

File Size: 207,37 KB

Share Result on Facebook

City

Berlin / /

Company

Merz Pharmaceuticals / BfArM / Allergan Inc. / BoNT Expert Working Group / Ipsen Biopharm Limited / Stephens / /

Continent

Europe / /

/

Event

Business Partnership / /

Facility

Federal Institute / Free University / Botulinum Neurotoxin Product Testing FEDERAL INSTITUTE FOR RISK ASSESSMENT Federal Institute / German Federal Institute / /

/

IndustryTerm

final reconstituted product / final product / manufacturing process / /

MedicalCondition

paralysis / cervical dystonia / medical disorders / blepharospasm / toxic syndrome / /

MedicalTreatment

relaxation / /

Organization

EWG / Center for Alternative Methods / BoNT EWG Scope and Objectives / Federal Institute for Drugs and Medical Devices / Hannover Medical School / Botulinum Neurotoxin Product Testing FEDERAL INSTITUTE FOR RISK ASSESSMENT Federal Institute for Risk Assessment / European Union / German Federal Institute for Risk Assessment / Free University / /

Person

Joan Fitzgerald / Barbara Grune / Dorothea Sesardic / Dirk Dressler / Klaus Fink / Manfred Liebsch Medicinal / Marlies Halder / Manfred Liebsch / Andy Pickett / Chris Bishop / Vincent Irwin / Jean-Marc Spieser / Anja Düchting / Andreas Luch / Sarah Adler / René Thürmer / Horst Spielmann / Nicole Bornstein / /

/

Position

Bishop / chair / /

PublishedMedium

the BoNT EWG Drying Review / /

URL

http /

SocialTag